← Back to all clusters

Cluster 383

5 diseases · 8 shared-gene connections
5 Diseases
18 Unique genes
0.180 Avg. similarity score
C1 esterase inhibitor deficiency Most-connected disease (4 links)
Log in to save this analysis

Save This Analysis

Disease Searched: C9 deficiency Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details · click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) · drag a node to pin it in place · scroll/pinch to zoom.

Member diseases (most connected first ‐ the cluster's core)

Disease ⇵ Connections in cluster ⇵ Significant partners ⇵ Curated genes ⇵
C1 esterase inhibitor deficiency 4 4 6
Complement component deficiency 4 4 17
C9 deficiency 3 3 1
Terminal complement component deficiency 3 3 7
Hereditary c1 esterase inhibitor deficiency 2 2 1

Top shared genes (genes linked to 2+ member diseases)

Gene ⇵ Member diseases ⇵ Linked diseases
C9 4 / 5 C1 esterase inhibitor deficiency, C9 deficiency, Complement component deficiency, Terminal complement component deficiency
C8A 3 / 5 C1 esterase inhibitor deficiency, Complement component deficiency, Terminal complement component deficiency
C8B 3 / 5 C1 esterase inhibitor deficiency, Complement component deficiency, Terminal complement component deficiency
SERPING1 3 / 5 C1 esterase inhibitor deficiency, Complement component deficiency, Hereditary c1 esterase inhibitor deficiency
C2 2 / 5 C1 esterase inhibitor deficiency, Complement component deficiency
C4B 2 / 5 C1 esterase inhibitor deficiency, Complement component deficiency
C5 2 / 5 Complement component deficiency, Terminal complement component deficiency
C6 2 / 5 Complement component deficiency, Terminal complement component deficiency
C7 2 / 5 Complement component deficiency, Terminal complement component deficiency
What do these columns mean?
Connections in cluster
How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
Significant partners
How many of those links are statistically significant (FDR q < 0.05).
Curated genes
Distinct curated genes linked to that disease in GeDiPNet.
Member diseases (Top shared genes)
How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
Overlap genes (x / y)
x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
Cluster gene count
Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
Fold enrichment
Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
P-value / FDR q-value
Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
Shared genes (Pairs within this cluster)
Number of curated genes the two diseases in that row have in common.
Similarity score (Pairs within this cluster)
Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.

Enriched Pathways (why this cluster is grouped, biologically)

Pathway ⇵ Source ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
Regulation of Complement cascade Reactome 16 / 47 227× 2.58e-38 1.59e-34 ✓ sig.
Complement and coagulation cascades KEGG 17 / 88 129× 1.75e-36 8.48e-33 ✓ sig.
Coronavirus disease - COVID-19
C2, C4B, C8A, C8B, C9, CFB, C3, C4A, C5, C6, C7, C1S
KEGG 14 / 238 39.2× 2.80e-21 2.45e-18 ✓ sig.
Terminal pathway of complement
C8A, C8B, C9, C5, C6, C7, C8G
Reactome 7 / 8 584× 3.56e-20 2.66e-17 ✓ sig.
Systemic lupus erythematosus
C2, C4B, C8A, C8B, C9, C3, C4A, C5, C6, C7, C1S, C8G
KEGG 12 / 140 57.2× 6.82e-20 4.86e-17 ✓ sig.
Staphylococcus aureus infection
C2, C4B, CFB, C3, C4A, C5, C1S, CFD, CFH, CFI
KEGG 10 / 99 67.4× 3.77e-17 1.77e-14 ✓ sig.
Activation of C3 and C5
C2, C4B, CFB, C3, C4A, C5
Reactome 6 / 8 500× 1.25e-16 5.38e-14 ✓ sig.
Pertussis KEGG 7 / 78 59.9× 1.11e-11 2.00e-9 ✓ sig.
Initial triggering of complement Reactome 4 / 17 157× 8.30e-9 7.81e-7 ✓ sig.
Regulation of actin cytoskeleton
C8A, C8B, C9, C5, C6, C7, C8G
KEGG 7 / 232 20.1× 2.44e-8 2.01e-6 ✓ sig.
Alternative complement activation Reactome 3 / 5 400× 2.82e-8 2.29e-6 ✓ sig.
Prion disease
C8A, C8B, C9, C5, C6, C7, C8G
KEGG 7 / 275 17.0× 7.84e-8 5.66e-6 ✓ sig.
Alcoholic liver disease
C2, C4B, C3, C4A, C5
KEGG 5 / 144 23.2× 1.75e-6 8.45e-5 ✓ sig.
Amoebiasis KEGG 4 / 103 25.9× 1.42e-5 4.74e-4 ✓ sig.
Post-translational protein phosphorylation Reactome 3 / 108 18.5× 5.23e-4 8.56e-3 ✓ sig.

Enriched GO Terms (Biological Process, a second line of biological evidence)

GO term ⇵ GO ID ⇵ Overlap genes ⇵ Fold enrichment ⇵ P-value ⇵ FDR q-value ⇵
complement activation
C2, C4B, C8A, C8B, C9, CFB, C3, C4A, C5, C6, C7, C1S
GO:0006956 16 / 35 475× 5.90e-44 7.45e-40 ✓ sig.
complement activation, GZMK pathway
C2, C4B, C8A, C8B, C9, C3, C4A, C5, C6, C7, C8G
GO:0160257 11 / 12 952× 1.58e-34 1.05e-30 ✓ sig.
complement activation, classical pathway
C2, C4B, C8A, C8B, C9, C3, C4A, C5, C6, C7, C1S, CFI
GO:0006958 13 / 37 365× 5.60e-33 3.60e-29 ✓ sig.
complement activation, alternative pathway
C8A, C8B, C9, CFB, C3, C5, C7, CFD, CFH, C8G
GO:0006957 10 / 16 649× 2.45e-28 1.14e-24 ✓ sig.
killing of cells of another organism
C2, C8A, C8B, C9, CFB, C3, C4A, C5, C6, C7, C1S, C8G
GO:0031640 12 / 104 120× 8.28e-24 2.34e-20 ✓ sig.
innate immune response
C2, C4B, C8A, C8B, C9, CFB, C3, C4A, C5, C6, C7, C1S
GO:0045087 16 / 605 27.5× 1.73e-22 3.97e-19 ✓ sig.
immune system process
C2, C4B, C8A, C8B, C9, CFB, C3, C4A, C5, C6, C7, C1S
GO:0002376 16 / 943 17.6× 2.18e-19 3.08e-16 ✓ sig.
activation of membrane attack complex GO:0001905 5 / 13 399× 5.78e-13 2.76e-10 ✓ sig.
positive regulation of immune response
C8A, C8B, C9, C6, C7, C8G
GO:0050778 6 / 40 156× 1.18e-12 5.40e-10 ✓ sig.
opsonization GO:0008228 5 / 18 288× 3.84e-12 1.58e-9 ✓ sig.
positive regulation of apoptotic cell clearance GO:2000427 4 / 6 692× 9.03e-12 3.36e-9 ✓ sig.
complement activation, lectin pathway
C2, C3, C4A, C5
GO:0001867 4 / 13 319× 4.28e-10 1.06e-7 ✓ sig.
protein maturation GO:0051604 6 / 134 46.5× 2.10e-9 4.34e-7 ✓ sig.
immune response
C8A, C8B, C9, C3, C6, C7
GO:0006955 6 / 543 11.5× 8.07e-6 4.57e-4 ✓ sig.
response to bacterium GO:0009617 4 / 140 29.7× 8.51e-6 4.77e-4 ✓ sig.

Pairs within this cluster, by significance

Disease A ⇵ Disease B ⇵ Similarity score ⇵ Shared genes ⇵ P-value ⇵ FDR q-value ⇵
C1 esterase inhibitor deficiency Complement component deficiency 0.333 6 6.69e-19 1.20e-17 ✓ sig.
Complement component deficiency Terminal complement component deficiency 0.316 6 4.68e-18 8.09e-17 ✓ sig.
C1 esterase inhibitor deficiency Terminal complement component deficiency 0.273 3 1.15e-9 1.04e-8 ✓ sig.
C1 esterase inhibitor deficiency Hereditary c1 esterase inhibitor deficiency 0.143 1 3.90e-4 8.67e-4 ✓ sig.
C1 esterase inhibitor deficiency C9 deficiency 0.143 1 3.90e-4 8.67e-4 ✓ sig.
C9 deficiency Terminal complement component deficiency 0.125 1 4.55e-4 9.73e-4 ✓ sig.
C9 deficiency Complement component deficiency 0.056 1 1.10e-3 1.83e-3 ✓ sig.
Complement component deficiency Hereditary c1 esterase inhibitor deficiency 0.056 1 1.10e-3 1.83e-3 ✓ sig.